Coya Therapeutics, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses), averaging +20.1% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.36 | $-0.28 | +22.2% | Beat | |
| Q1 FY26 | $-0.39 | $-0.32 | +17.9% | Beat | |
| Q4 FY25 | not reported | $-0.34 | not reported | not reported |
Back to COYA overview · COYA holders · COYA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.